ALVO SDB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Alvotech is a biotechnology company that focuses on the development and manufacture of biosimilar medicines. The company's pipeline consists of biosimilar candidates aimed at treating autoimmune diseases, eye diseases, osteoporosis and cancer. The company offers its products to patients all over the world. Alvotech was founded in 2013 and has its headquarters in Reykjavík.
Read moreInterim report Q2'26
Interim report Q3'26
Annual report '26
Revenue B
EBIT-% (adj.)
EPS (adj.)
Dividend %
Don't miss out - create an account and get all the possible benefits